Charles Schwab
SZYM

Charles Schwab’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Charles Schwab’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-239,661
Closed -$487K – 3203
2016
Q1 		$487K Buy
239,661
+4,845
+2% +$8.64K ﹤0.01% 2589
2015
Q4 		$583K Buy
234,816
+6,175
+3% +$18.3K ﹤0.01% 2583
2015
Q3 		$595K Buy
228,641
+55,499
+32% +$145K ﹤0.01% 2561
2015
Q2 		$544K Buy
173,142
+3,854
+2% +$13.2K ﹤0.01% 2643
2015
Q1 		$485K Buy
169,288
+45,688
+37% +$117K ﹤0.01% 2638
2014
Q4 		$319K Sell
123,600
-55,951
-31% -$245K ﹤0.01% 2824
2014
Q3 		$1.34M Buy
179,551
+3,318
+2% +$31K ﹤0.01% 2177
2014
Q2 		$2.08M Buy
176,233
+42,856
+32% +$457K ﹤0.01% 1964
2014
Q1 		$1.55M Buy
133,377
+3,894
+3% +$45.8K ﹤0.01% 2072
2013
Q4 		$1.41M Buy
129,483
+5,106
+4% +$50.2K ﹤0.01% 2101
2013
Q3 		$1.37M Buy
124,377
+12,773
+11% +$145K ﹤0.01% 2058
2013
Q2 		$1.31M Buy
+111,604
New +$1.11M ﹤0.01% 2001

Charles Schwab's SZYM Position: Q2 2016 in Review

Charles Schwab sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 239,661 shares — an estimated $487K sold.

Charles Schwab first reported a position in SZYM in Q2 2013 and held it in 12 quarters. The position peaked at $2.08M in Q2 2014. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • Charles Schwab reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Charles Schwab sold 239,661 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $487K.
  • Charles Schwab first reported a position in SOLAZYME INC COM STK (DE) in Q2 2013 and held it in 12 quarters.
  • Charles Schwab's SOLAZYME INC COM STK (DE) position peaked at $2.08M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Charles Schwab's 13F filing for Q2 2016, filed 15 Aug 2016.